An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
Clinical trial NCT01646827 · COMPLETED
Trial details
- NCT number
- NCT01646827
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-04-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.